# Sibylla Biotech: Research, Bresso, Italy

> Sibylla Biotech: Sibylla Biotech is a preclinical-stage biotechnology company based in Italy, focused on drug discovery for currently incurable diseases.

Source: https://millionrounds.com/startup/sibylla-biotech (Millionrounds; every figure on the page links to its filing or article)

Italy · [Research startup](https://millionrounds.com/companies)

# Sibylla Biotech

Sibylla Biotech is a preclinical-stage biotechnology company based in Italy, focused on drug discovery for currently incurable diseases.

Email

Funding reported Last round: Series A

Research Bresso, Italy

Follow Sibylla Biotech and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fsibylla-biotech)

Company summary

- **Founded:** 2017 9 years old
- **Team:** 42 11 to 50 people
- **Funding reported:** 23M as listed, currency not stated
- **Last round:** Series A Oct 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Sibylla Biotech has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Sibylla Biotech

Sibylla Biotech is a preclinical-stage biotechnology company based in Italy, focused on drug discovery for currently incurable diseases.

Founded as a spin-off from the Italian National Institute for Nuclear Physics and local universities, the company has developed a unique platform that utilizes computer simulations and AI to create small molecule degraders. This innovative approach, known as Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT), allows Sibylla to target previously inaccessible protein structures, enabling the design of therapeutic solutions across various therapeutic areas, including oncology and viral infections. The company has gained recognition for its contributions to the life sciences field, being named one of the best start-ups globally by *Nature*. Sibylla secured €23 million in Series A financing to advance its proprietary pipeline and offers collaborative partnerships to pharmaceutical companies for drug discovery and preclinical studies. With a mission to treat diseases deemed untreatable, Sibylla Biotech is positioned to make significant advancements in the targeted protein degradation field.

## What company datasets say Sibylla Biotech raised

Funding, as reported

Reported in all **23M** in the source's currency

Rounds **1**

Last round **Series A**

Last round size **25.3M**

Last round date **Oct 2022**

Investors listed **8**

## Founders and team

From Sibylla Biotech's own website: 6 founders, 24 on the team.

**Giovanni Spagnolli** Co-founder & CTO

**Lidia Pieri** Co-founder & COO

**Emiliano Biasini** Scientific co-founder

**Graziano Lolli** Scientific co-founder

**Maria Letizia Barreca** Scientific co-founder

**Pietro Faccioli** Scientific co-founder

- **Usman Azam** CEO
- **Gianluca Fuggetta** CFO
- **Alexandros Patsilinakos** Head of Medicinal Chemistry Discovery Lab
- **Enrica Colasurdo** Head of Computational Lab
- **Gianluca Papeo** Head of Medicinal Chemistry Development Lab
- **Serena Bonifati** Head of Assay Biology
- **Simone Lanfredini** Head of In vivo Pharmacology
- **Alessandro Galbiati** Director of Biology
- **Carmine Varricchio** Principal Scientist
- **Cassiano Langini** Senior Scientist
- **Ciro Spedaliere** Board member
- **Dieter Weinand** Chairman
- **Fabiana Russo** Senior Principal Scientist
- **Giovanni Rizzo** Board member
- **Giulia Frapporti** Senior Scientist
- **Laura Raggi** Senior Scientist
- **Leda Bencheva** Senior Principal Scientist
- **Marianne Bjordal** Board member

And 6 more on the team.

## On 5 portfolio pages

Investors who name them

- [3B Future Health Fund I & II](https://millionrounds.com/fund/3b-future-health-fund-i-and-ii)
- [V-Bio Ventures](https://millionrounds.com/fund/v-bio-ventures)
- [Seroba.](https://millionrounds.com/fund/seroba)
- [CDP Venture Capital](https://millionrounds.com/fund/cdp-venture-capital)
- [Seroba Life Sciences](https://millionrounds.com/fund/seroba-life-sciences)

Each firm lists Sibylla Biotech on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care folding intermediates co-translational folding biotechnology research protein folding simulations targeted protein inactivation neurodegenerative diseases protein misfolding information technology & services biotech collaborations computational drug design hospital & health care computational biophysics oncology therapeutics medical physics-based modeling

Built with from their website

Google Tag Manager WordPress.org YouTube Google Workspace Viewport Meta Apple Business Manager Google Meet Priority Hints Google Font API FitVids.JS

+8 more

Cookiebot MySQL PrimeNG Mobile Friendly Open Graph jQuery RSS Yoast SEO

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Lombardia
- **Revenue:** 4.1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/sibylla-biotech)

## Research in Italy

Startups like it

- [**Genespire** Milan · founded 2020](https://millionrounds.com/startup/genespire)
- [**Aptadir Therapeutics** Milano](https://millionrounds.com/startup/aptadir-therapeutics)
- [**Resalis Therapeutics** Turin · founded 2021](https://millionrounds.com/startup/resalis-therapeutics)
- [**Algorithmiq** Milano · founded 2020](https://millionrounds.com/startup/algorithmiq)
- [**Phononic Vibes** Milan · founded 2018](https://millionrounds.com/startup/phononic-vibes-2)
- [**Contraria Biotech** Siena · founded 2017](https://millionrounds.com/startup/contraria-biotech)
- [**Cellply** Bologna · founded 2013](https://millionrounds.com/startup/cellply)
- [**Altheia Science** Milan · founded 2017](https://millionrounds.com/startup/altheia-science)

## Is this your company?

Add your raise, your deck and your story, and put Sibylla Biotech in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)